Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

This study is testing two new drugs, EXV-802 and EXV-801, to see if they are safe and effective at reducing agitation in people with Alzheimer's disease dementia — a common and distressing symptom where patients become physically or verbally aggressive, restless, or extremely unsettled. **You may be eligible if...** - You are between 55 and 90 years old - You have a diagnosis of Alzheimer's disease dementia - You have significant agitation that has been present for at least 2 weeks before the study - Your agitation meets the formal International Psychogeriatric Association definition - You can move around on your own, with a walker, or in a wheelchair - You have a caregiver who can be with you at least 2 hours a day on 4 days per week and is willing to help with study requirements **You may NOT be eligible if...** - Your primary diagnosis is a different type of dementia (not Alzheimer's) - Your agitation is mild and does not meet the clinical threshold - You do not have a reliable caregiver available Talk to your doctor to see if this trial is right for you.